A indústria de cannabis medicinal do Brasil entrou em um novo capítulo em 4 de maio de 2026. Após sete anos sob o marco regulatório provisório da RDC 327/2019,…
Read MoreBrazil’s Cannabis New Era Begins: ANVISA’s RDC 1,015 Takes Effect and Reshapes Latin America’s Largest Medical Market
Brazil’s medical cannabis industry entered a new chapter on May 4, 2026. After seven years under the provisional framework of RDC 327/2019, ANVISA’s…
Read MoreSaint Lucia Selects GrowerIQ to Power National Cannabis Traceability Programme
Saint Lucia’s Regulated Substances Authority selects GrowerIQ through formal RFP to build national seed-to-sale traceability platform. Second Caribbean nation after Barbados.
Read MoreAustralia’s Billion-Dollar Cannabis Milestone: 41 Cultivators, 41 Tonnes, and a Market That Won’t Stop Growing
Australia’s medical cannabis market crossed the AUD $1 billion mark in 2025. That single figure captures a transformation that has unfolded with remarkable…
Read MoreALCOA++ Data Integrity for Cannabis Manufacturing
Learn how the 10 ALCOA++ data integrity principles apply to cannabis manufacturing. Covers Health Canada GPP requirements, common audit findings, and practical guidance for moving from paper to digital.
Read MoreGrowerIQ Becomes First International Seed-to-Sale Platform to Enter Brazil
GrowerIQ has become the first international seed-to-sale platform to formalize operations in Brazil through a strategic alliance with Milgrows, positioning compliance infrastructure ahead of ANVISA’s August 4, 2026 cultivation deadline.
Read More



